Browsing by Author "Bahceci, A."
Now showing items 1-4 of 4
-
Efficacy and tolerability of first-line chemotherapy in elderly patients ( age >= 70 years) with metastatic gastric cancer: a multicenter study of the Anatolian Society of Medical Oncology (ASMO)
Aldemir, M. N.; Turkeli, M.; Hacioglu, B.; Sakin, A.; Yaman, E.; Coban, E.; Koca, D.; Karaca, M.; Simsek, M.; Bahceci, A.; Sen, E.; Eren, T.; Aliustaoglu, B. O.; Sakalar, T.; Kalkan, N. O.; Aktas, G.; Bilici, M.; Turhal, S.; Benekli, M.; Tekin, S. B. (OXFORD UNIV PRESS, 2016)… -
Prognostic value of serum Tie-2 and vascular endothelial growth factor levels in cancer patients
Seker, M. M.; Sancaktar, E.; Acibucu, D. O.; Filiz, A. K.; Deveci, K.; Bahceci, A.; Kacan, T.; Babacan, N.; Yuce, S. (VERDUCI PUBLISHER, 2013)BACKGROUND: Angiogenesis is a very essential process in tumor biology. Vascular endothelial growth factor (VEGF), angiopoietin and its receptor (TIE-2) are very important mediators for angiogenesis. In this trial, we aimed ... -
Treatment and prognosis of breast cancer in elderly: Different from young patients?
Seker, M. Metin; Yucel, B.; Seker, A.; Eren, A. Ay; Bahar, S.; Celasun, G.; Kacan, T.; Eren, M. Fuat; Babacan, N.; Bahceci, A. (SPRINGER, 2014)Purpose: The incidence of breast cancer increases with advanced age; 80% of patients are older then 50 years and 40% of patients are older then 65 years. But clinical trials including elderly patient are unsatisfactory. ...